vida: extract from 2025-03-26-crfb-ma-overpaid-1-2-trillion.md
- Source: inbox/archive/2025-03-26-crfb-ma-overpaid-1-2-trillion.md - Domain: health - Extracted by: headless extraction cron (worker 6) Pentagon-Agent: Vida <HEADLESS>
This commit is contained in:
parent
ba4ac4a73e
commit
0bbc431e83
5 changed files with 112 additions and 1 deletions
|
|
@ -34,6 +34,12 @@ The broader 2027 rate environment compounds the pressure into a three-pronged sq
|
|||
|
||||
This is a proxy inertia story. Since [[proxy inertia is the most reliable predictor of incumbent failure because current profitability rationally discourages pursuit of viable futures]], the incumbents who built their MA economics around coding optimization will struggle to shift toward genuine quality competition. The plans that never relied on coding arbitrage (Devoted, Alignment, Kaiser) are better positioned.
|
||||
|
||||
|
||||
### Additional Evidence (confirm)
|
||||
*Source: [[2025-03-26-crfb-ma-overpaid-1-2-trillion]] | Added: 2026-03-12 | Extractor: anthropic/claude-sonnet-4.5*
|
||||
|
||||
CRFB analysis confirms that coding intensity generates $600B in MA overpayments over 2025-2034, even after CMS's current 5.9% coding adjustment. MA plans achieve a 10% net payment increase from coding practices, translating to $260B in trust fund impact and $110B in beneficiary premium costs. The CMS 2027 chart review exclusion is one policy response, but CRFB notes that raising the minimum coding adjustment from 5.9% to 20% could reduce deficits by over $1 trillion—suggesting current adjustments are insufficient. This supports the claim that chart review exclusion targets the profit arbitrage mechanism, though the scale of potential savings ($1T from coding adjustment alone) indicates the 2027 policy may be a partial rather than complete solution.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -0,0 +1,41 @@
|
|||
---
|
||||
type: claim
|
||||
domain: health
|
||||
description: "Prior authorization and narrow networks create self-selection of healthier beneficiaries worth $580B over a decade, which is structural rather than fraudulent"
|
||||
confidence: likely
|
||||
source: "Committee for a Responsible Federal Budget via MedPAC data, March 2025"
|
||||
created: 2026-03-11
|
||||
---
|
||||
|
||||
# Favorable selection in Medicare Advantage is structural not fraudulent because plan design features discourage high-utilizers
|
||||
|
||||
Medicare Advantage plans achieve $580 billion in overpayments (2025-2034) through favorable selection—attracting healthier beneficiaries who cost less to treat than the risk-adjusted payments they generate. Unlike coding intensity, which involves documentation practices that CMS can audit and adjust, favorable selection is embedded in legitimate plan design choices.
|
||||
|
||||
**The mechanism:** MA plans use prior authorization requirements and narrow provider networks as utilization management tools. These features are presented as cost control mechanisms, but they have a secondary effect: they discourage enrollment by beneficiaries who anticipate high healthcare needs. Patients expecting frequent specialist visits or specific treatments self-select away from plans with restrictive networks. Patients anticipating complex care avoid plans with aggressive prior authorization.
|
||||
|
||||
The result is an 11% cost differential between MA and traditional Medicare in 2025, driven not by better care management but by healthier patient populations. This selection advantage is:
|
||||
- **Legal:** Plan design features are within regulatory bounds
|
||||
- **Rational:** Plans maximize profit by attracting low-cost members
|
||||
- **Structural:** The incentive persists as long as risk adjustment is imperfect
|
||||
- **Unprosecutable:** There's no fraud to investigate
|
||||
|
||||
The $580B favorable selection impact splits into $250B in trust fund costs and $110B in beneficiary premium increases. Policy options to address this require changing payment methodology or plan design regulations, not fraud enforcement.
|
||||
|
||||
## Evidence
|
||||
|
||||
- $580B in favorable selection overpayments over 2025-2034 (MedPAC data)
|
||||
- 11% increased MA costs vs FFS in 2025 from selection alone
|
||||
- Prior authorization and narrow networks identified as selection mechanisms
|
||||
- $250B Medicare HI Trust Fund impact
|
||||
- $110B beneficiary premium impact
|
||||
- Selection effect is structural, not fraudulent
|
||||
|
||||
## Challenges
|
||||
|
||||
MA plans argue that lower costs reflect better care coordination and prevention, not just healthier populations. Disentangling selection effects from genuine efficiency gains is methodologically difficult. However, the persistence of cost differentials even after risk adjustment suggests selection plays a substantial role.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
- value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md
|
||||
- CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring.md
|
||||
|
|
@ -0,0 +1,42 @@
|
|||
---
|
||||
type: claim
|
||||
domain: health
|
||||
description: "MedPAC data shows MA overpayments split evenly between upcoding ($600B) and healthier patient selection ($580B) over 2025-2034"
|
||||
confidence: likely
|
||||
source: "Committee for a Responsible Federal Budget, Medicare Advantage Will Be Overpaid by $1.2 Trillion (2025-2034), March 2025"
|
||||
created: 2026-03-11
|
||||
depends_on:
|
||||
- "value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md"
|
||||
---
|
||||
|
||||
# Medicare Advantage overpayments total $1.2 trillion over 2025-2034 driven equally by coding intensity and favorable selection
|
||||
|
||||
Medicare Advantage plans will receive $1.2 trillion in overpayments relative to traditional Medicare between 2025 and 2034, according to MedPAC data analyzed by CRFB. This overpayment splits nearly evenly between two mechanisms:
|
||||
|
||||
**Coding intensity ($600B):** MA plans document diagnoses more aggressively than traditional Medicare, generating a 10% net payment increase even after CMS's 5.9% coding adjustment. This translates to $260B in Medicare HI Trust Fund impact and $110B in increased beneficiary premiums.
|
||||
|
||||
**Favorable selection ($580B):** MA plans attract healthier beneficiaries through plan design features like prior authorization and narrow networks that discourage care-seeking behavior. This structural selection advantage creates an 11% cost differential versus fee-for-service Medicare in 2025 alone, contributing $250B to trust fund depletion and $110B to premium increases.
|
||||
|
||||
The combined trust fund impact of ~$510B over the decade makes MA overpayments one of the largest single drivers of Medicare spending growth. CBO estimates that reducing MA benchmarks could save $489B, while raising the minimum coding adjustment from 5.9% to 20% could reduce deficits by over $1 trillion.
|
||||
|
||||
## Evidence
|
||||
|
||||
- MedPAC data showing $1.2T total overpayment projection (2025-2034)
|
||||
- Coding intensity creates 10% net payment increase despite 5.9% CMS adjustment
|
||||
- Favorable selection drives 11% increased MA costs vs FFS in 2025
|
||||
- Combined trust fund impact: $510B ($260B coding + $250B selection)
|
||||
- Combined beneficiary premium impact: $220B ($110B coding + $110B selection)
|
||||
- CBO policy option: benchmark reduction saves $489B
|
||||
- CBO policy option: 20% coding adjustment reduces deficits by >$1T
|
||||
|
||||
## Significance
|
||||
|
||||
This claim quantifies the fiscal unsustainability of unreformed Medicare Advantage. The symmetry between coding intensity and favorable selection is particularly important: policy debate focuses on upcoding fraud, but favorable selection is almost exactly as large—and it's structural, not illegal. MA plans benefit from attracting healthier members through plan design, and there's no fraud to prosecute.
|
||||
|
||||
The $1.2T overpayment occurs during the same decade when the Medicare HI Trust Fund faces insolvency (now projected for 2040). This creates a fiscal collision course where MA payment structure directly accelerates trust fund depletion.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
- value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md
|
||||
- CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring.md
|
||||
|
|
@ -23,6 +23,12 @@ The Making Care Primary model's termination in June 2025 (after just 12 months,
|
|||
|
||||
PACE represents the extreme end of value-based care alignment—100% capitation with full financial risk for a nursing-home-eligible population. The ASPE/HHS evaluation shows that even under complete payment alignment, PACE does not reduce total costs but redistributes them (lower Medicare acute costs in early months, higher Medicaid chronic costs overall). This suggests that the 'payment boundary' stall may not be primarily a problem of insufficient risk-bearing. Rather, the economic case for value-based care may rest on quality/preference improvements rather than cost reduction. PACE's 'stall' is not at the payment boundary—it's at the cost-savings promise. The implication: value-based care may require a different success metric (outcome quality, institutionalization avoidance, mortality reduction) than the current cost-reduction narrative assumes.
|
||||
|
||||
|
||||
### Additional Evidence (extend)
|
||||
*Source: [[2025-03-26-crfb-ma-overpaid-1-2-trillion]] | Added: 2026-03-12 | Extractor: anthropic/claude-sonnet-4.5*
|
||||
|
||||
CRFB analysis of MedPAC data quantifies the fiscal stakes of incomplete risk transfer in Medicare Advantage: $1.2 trillion in overpayments over 2025-2034, with $510B impacting the Medicare HI Trust Fund directly. The overpayment splits evenly between coding intensity ($600B) and favorable selection ($580B). This demonstrates that when payment systems touch value metrics without bearing full risk, the result is not just stalled transitions but massive fiscal transfers. MA plans receive risk-adjusted payments but use plan design (prior authorization, narrow networks) to attract healthier populations, capturing the upside of risk adjustment without the downside of true population health responsibility. CBO estimates that policy interventions (reducing benchmarks or raising coding adjustments to 20%) could save $489B to over $1 trillion, but these remain unimplemented—illustrating how payment boundary problems persist even when solutions are known and quantified.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -7,9 +7,15 @@ date: 2025-03-26
|
|||
domain: health
|
||||
secondary_domains: []
|
||||
format: report
|
||||
status: unprocessed
|
||||
status: processed
|
||||
priority: high
|
||||
tags: [medicare-advantage, overpayment, fiscal-impact, coding-intensity, favorable-selection, trust-fund]
|
||||
processed_by: vida
|
||||
processed_date: 2026-03-11
|
||||
claims_extracted: ["medicare-advantage-overpayments-total-1-2-trillion-over-2025-2034-driven-equally-by-coding-intensity-and-favorable-selection.md", "favorable-selection-in-medicare-advantage-is-structural-not-fraudulent-because-plan-design-features-discourage-high-utilizers.md"]
|
||||
enrichments_applied: ["value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md", "CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring.md"]
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
extraction_notes: "Extracted two claims: (1) the $1.2T overpayment headline with symmetric coding/selection drivers, and (2) the structural nature of favorable selection as a distinct mechanism. Enriched two existing claims with fiscal quantification and policy option data. The favorable selection mechanism is the less-discussed half of MA overpayments and deserved standalone treatment—it's legal, structural, and unprosecutable, unlike coding intensity which can be addressed through audits and adjustments. Connection to proxy inertia: MA plans' current profitability from these mechanisms creates rational resistance to payment reform."
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -50,3 +56,13 @@ tags: [medicare-advantage, overpayment, fiscal-impact, coding-intensity, favorab
|
|||
PRIMARY CONNECTION: [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]]
|
||||
WHY ARCHIVED: Quantifies the fiscal stakes of MA reform — connects insurance market structure to Medicare solvency timeline.
|
||||
EXTRACTION HINT: The favorable selection mechanism deserves its own claim — it's the less-discussed half of the overpayment equation.
|
||||
|
||||
|
||||
## Key Facts
|
||||
- MA overpayments total $1.2 trillion over 2025-2034 (MedPAC data)
|
||||
- Coding intensity: $600B ($260B trust fund, $110B premiums)
|
||||
- Favorable selection: $580B ($250B trust fund, $110B premiums)
|
||||
- CBO benchmark reduction option: $489B savings
|
||||
- CBO 20% coding adjustment option: >$1T deficit reduction
|
||||
- MA plans see 10% net payment increase from coding after 5.9% CMS adjustment
|
||||
- Favorable selection creates 11% cost differential vs FFS in 2025
|
||||
|
|
|
|||
Loading…
Reference in a new issue